1. About the Center for Drug Evaluation and Research>The Biopharmaceutics Classification System (BCS) Guidance [WWW Document], n.d. URL http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm128219.htm (accessed 2.19.16).
2. Response to imatinib mesylate in patients with chronic Myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor Beta;Apperley;N. Engl. J. Med.,2002
3. Structure, solubility, screening, and synthesis of molecular salts;Black;J. Pharm. Sci.,2007
4. Bridging solubility between drug discovery and development;Di;Drug Discov. Today,2012
5. Physicochemical and Crystallographic Investigations Into the Salt Formation of Two Heterocyclic Drugs;Elder,1992